APA (7th ed.) Citation

Xu, Y., Liu, S., Hao, F., & Zhang, Y. (2018). Recombinant adenovirus p53 combined with radiotherapy improves efficacy and safety in the treatment of head and neck lymphoma. Cancer Biomarkers, 23(2), 213. https://doi.org/10.3233/CBM-181286

Chicago Style (17th ed.) Citation

Xu, Yong-Hua, Shuo-Hui Liu, Fu-Rong Hao, and Yin-Huan Zhang. "Recombinant Adenovirus P53 Combined with Radiotherapy Improves Efficacy and Safety in the Treatment of Head and Neck Lymphoma." Cancer Biomarkers 23, no. 2 (2018): 213. https://doi.org/10.3233/CBM-181286.

MLA (9th ed.) Citation

Xu, Yong-Hua, et al. "Recombinant Adenovirus P53 Combined with Radiotherapy Improves Efficacy and Safety in the Treatment of Head and Neck Lymphoma." Cancer Biomarkers, vol. 23, no. 2, 2018, p. 213, https://doi.org/10.3233/CBM-181286.